Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Forsyth

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Human Brain Mapping|December 7, 2019
Modulation of simultaneously collected hemodynamic and electrophysiological functional connectivity by ketamine and midazolamAnna Forsyth, Rebecca McMillan, Doug Campbell, et al.
Psychopharmacology|November 15, 2018
Comparison of local spectral modulation, and temporal correlation, of simultaneously recorded EEG/fMRI signals during ketamine and midazolam sedationAnna Forsyth, Rebecca McMillan, Doug Campbell, et al.
Nature Communications|September 9, 2025
Local activity alterations in individuals with autism correlate with neurotransmitter properties and ketamine-induced brain changesPascal Grumbach, Jan Kasper, Joerg F Hipp, et al.
Medrxiv : the Preprint Server for Health Sciences|November 6, 2024
Local activity alterations in autism spectrum disorder correlate with neurotransmitter properties and ketamine induced brain changesPascal Grumbach, Jan Kasper, Joerg F Hipp, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorderRebecca McMillan, Rachael Sumner, Anna Forsyth, et al.
Journal of Oral Microbiology|September 10, 2019
Sex-specific differences in the salivary microbiome of caries-active childrenStephanie Ortiz, Elisa Herrman, Claudia Lyashenko, et al.
Frontiers in Pharmacology|March 23, 2026
Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm studyBen D Moloney, Anna Forsyth, Rachael L Sumner, et al.
Translational Psychiatry|April 15, 2024
LSD increases sleep duration the night after microdosingNathan Allen, Aron Jeremiah, Robin Murphy, et al.
Therapeutic Advances in Psychopharmacology|December 9, 2025
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trialCarina Joy Donegan, Dimitri Daldegan-Bueno, Rachael L Sumner, et al.
Neuropharmacology|September 1, 2025
Qualitative Content Analysis of Expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measuresCarina Joy Donegan, Dimitri Daldegan-Bueno, Tehseen Noorani, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Human Brain Mapping|December 7, 2019
Modulation of simultaneously collected hemodynamic and electrophysiological functional connectivity by ketamine and midazolamAnna Forsyth, Rebecca McMillan, Doug Campbell, et al.
Psychopharmacology|November 15, 2018
Comparison of local spectral modulation, and temporal correlation, of simultaneously recorded EEG/fMRI signals during ketamine and midazolam sedationAnna Forsyth, Rebecca McMillan, Doug Campbell, et al.
Nature Communications|September 9, 2025
Local activity alterations in individuals with autism correlate with neurotransmitter properties and ketamine-induced brain changesPascal Grumbach, Jan Kasper, Joerg F Hipp, et al.
Medrxiv : the Preprint Server for Health Sciences|November 6, 2024
Local activity alterations in autism spectrum disorder correlate with neurotransmitter properties and ketamine induced brain changesPascal Grumbach, Jan Kasper, Joerg F Hipp, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorderRebecca McMillan, Rachael Sumner, Anna Forsyth, et al.
Journal of Oral Microbiology|September 10, 2019
Sex-specific differences in the salivary microbiome of caries-active childrenStephanie Ortiz, Elisa Herrman, Claudia Lyashenko, et al.
Frontiers in Pharmacology|March 23, 2026
Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm studyBen D Moloney, Anna Forsyth, Rachael L Sumner, et al.
Translational Psychiatry|April 15, 2024
LSD increases sleep duration the night after microdosingNathan Allen, Aron Jeremiah, Robin Murphy, et al.
Therapeutic Advances in Psychopharmacology|December 9, 2025
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trialCarina Joy Donegan, Dimitri Daldegan-Bueno, Rachael L Sumner, et al.
Neuropharmacology|September 1, 2025
Qualitative Content Analysis of Expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measuresCarina Joy Donegan, Dimitri Daldegan-Bueno, Tehseen Noorani, et al.
Pageof 4